IDH Releases Q1 2024 Financial Results
(Cairo and London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Sudan and Saudi Arabia, announced today its reviewed financial statements for the quarter ended 31 March 2024, booking revenues of EGP 1,171 million, up 28% year-on-year. Revenue growth continued to be supported by increased test volumes and higher average revenues per test. Further down the income statement, IDH’s cost optimization initiatives resulted in improved profitability at all levels. During the quarter, the Group posted EBITDA of EGP 330 million, up 45% year-on-year and yielding an EBITDA margin of 28%. Meanwhile, the Company recorded net profit growth of 139% year-on-year to reach EGP 402 million, and yielding a net profit margin (NPM) of 34%.